GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

zovegalisib   Click here for help

GtoPdb Ligand ID: 13065

Synonyms: RLY-2608 | RLY2608
PDB Ligand
Compound class: Synthetic organic
Comment: RLY-2608 is a first-in-class allosteric mutant-selective PI3Kα inhibitor [2]. It was designed to treat PIK3CA mutant cancers, as an alternative to orthosteric inhibitors that are known to cause hyperglycemia via inhibition of wild-type (WT) PI3Kα and which can be rendered ineffective by secondary PI3Kα mutations [1]. The chemical structure was matched to INN zovegalisib which was included in WHO INN proposed list 133 (10th July 2025).
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

zovegalisib is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 109.95
Molecular weight 608.91
XLogP 1.45
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES C1=C(C=C(C(=C1)Cl)[C@H]2C3=C(C=C(C=C3C(=O)N2)C4=C(C#N)N5C(=NC=N5)C=C4)NC(=O)C6=CC(=CC(=C6)C(F)(F)F)F)F
Isomeric SMILES C1=CC(=C(C=C1F)[C@H]2C3=C(C=C(C=C3NC(=O)C4=CC(=CC(=C4)F)C(F)(F)F)C=5C=CC6=NC=NN6C5C#N)C(=O)N2)Cl
InChI InChI=1S/C29H14ClF5N6O2/c30-21-3-1-16(31)10-19(21)26-25-20(28(43)40-26)7-13(18-2-4-24-37-12-38-41(24)23(18)11-36)8-22(25)39-27(42)14-5-15(29(33,34)35)9-17(32)6-14/h1-10,12,26H,(H,39,42)(H,40,43)/t26-/m0/s1
InChI Key VYWRYBZVVSPTQN-SANMLTNESA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxo-2,3-dihydroisoindol-4-yl]-3-fluoro-5-(trifluoromethyl)benzamide
International Nonproprietary Names Click here for help
INN number INN
13750 zovegalisib
Synonyms Click here for help
RLY-2608 | RLY2608
Database Links Click here for help
CAS Registry No. 2733573-94-7 (source: PubChem)
GtoPdb PubChem SID 491299847
PubChem CID 166822065
RCSB PDB Ligand XUZ
Search Google for chemical match using the InChIKey VYWRYBZVVSPTQN-SANMLTNESA-N
Search Google for chemicals with the same backbone VYWRYBZVVSPTQN
Search PubMed clinical trials zovegalisib
Search PubMed titles zovegalisib
Search PubMed titles/abstracts zovegalisib
UniChem Compound Search for chemical match using the InChIKey VYWRYBZVVSPTQN-SANMLTNESA-N
UniChem Connectivity Search for chemical match using the InChIKey VYWRYBZVVSPTQN-SANMLTNESA-N

Product suppliers

View disclaimer

Sponsored products disclaimer

Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.

Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.

✖

MedChemExpress
RLY-2608 (links to external site)
Cat. No. HY-153306